Dr Vincent Launay-Vacher from Pitie-Salpetriere Hospital, Paris, France talks to ecancertv at ASCO GU congress 2014 about the results of the MARS study. This study is assessing the renovascular tolerance of anti-VEGF drugs in a clinical setting.
Dr Launay-Vacher also discusses the new Cancer & the Kidney International Network C-KIN